Evidence Level:Sensitive: C4 – Case Studies
Title:
Mucinous tubular and spindle-cell carcinoma of the kidney: Clinical features, genomic profiles, and treatment outcomes.
Excerpt:Four patients received systemic therapy with time to treatment failure ≤ 6 months across different agents with the exception of one patient with prolonged response on sunitinib (30.6 months)....The tumor of the patient who achieved long lived response on sunitinib harbored a total of 8 mutations including BAP1(I696T) missense mutation.
DOI:10.1016/j.clgc.2019.04.006